secwatch.observer — SEC 8-K summary
======================================

Issuer:     CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CIK:        0001187953
Form:       8-K
Filed at:   2024-05-17T23:59:59+00:00
Accession:  0001477932-24-003116
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 3.03, 5.03, 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO buys one Series B Preferred share with special voting rights on share increase; annual meeting July 19
--------------------------------------------------------------------------------

- CEO Timothy Warbington purchased one Series B Preferred share for $100; it carries 100M votes on share increase proposal.
- Series B Preferred votes proportionally with common stock on proposal to increase authorized common from 5M to 25M shares.
- Series B automatically redeemed upon approval of share increase; not convertible into common.
- Annual meeting of stockholders set for July 19, 2024; record date June 3, 2024.
- Preliminary proxy statement filed with SEC regarding share increase and other proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1187953/000147793224003116/0001477932-24-003116-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1187953/000147793224003116/celz_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-003116

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer